MartinsSM. Death from Cancer and Cardiovascular Disease between Two Brazils. Arq. Bras. Cardiol. 2020;114(2):207-8.
Martins,Sílvia Marinho. Death from Cancer and Cardiovascular Disease between Two Brazils. Arq. Bras. Cardiol., v. 114, n. 2, p. 207-208, Feb. 2020.
Martins,S.M. (2020). Death from Cancer and Cardiovascular Disease between Two Brazils. Arq. Bras. Cardiol.,114(2), 207-208.
Martins,Sílvia Marinho. Death from Cancer and Cardiovascular Disease between Two Brazils. Arq. Bras. Cardiol. [online]. 2020, vol. 114, n. 2, [cited 2025-09-09], pp.207-208. Available from: <https://abccardiol.org/en/short-editorial/death-from-cancer-and-cardiovascular-disease-between-two-brazils/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
